When implementing a randomization and trial supply management (RTSM) system for a clinical trial, there is a shared responsibility between the RTSM vendor and sponsor organizations to ensure the system performs as intended according to predefined requirements.
Trial designs are becoming more complex. Most of these trials are supported by legacy/older technologies that have limited flexibility to quickly adapt to new trial information. The pharmaceutical industry is reaching a tipping point, where the need for flexibility is outweighing the need to be conservative and risk-averse in this highly-regulated environment.
Understand the challenges facing clinical trials, and explore how a three-part framework for addressing them that leverages key emerging technologies and capabilities can help.
Can organizations implement today’s regulatory requirements using conventional approaches?
Embrace Agile IRT and realize the benefits that will ultimately accrue to the sites running studies and the patients.
A full-service, highly qualified partner who uses effective technology-enabled financial management services can help ensure efficient site payments, greater transparency into payments on all sides, and satisfied investigators.
How proactive planning to track missing patients will minimize their detrimental effect on study results.
Understand the benefits and challenges of conducting studies in Latin America in addition to some recent changes that could expedite regulatory timelines.
How global site networks can effectively address timeline, budget and data quality concerns, by providing access to multiple experienced sites within a single network, providing cost savings through reduction of the total number of sites used and recruitment of a large volume of patients.
Change the perception of clinical trials by making them less burdensome for patients overall.
|
|
|
|
|
|
|
|
|